文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

低剂量氯胺酮对颅内肿瘤切除术患者围术期抑郁症状影响的随机对照试验方案

Effect of low-dose ketamine on PerioperAtive depreSsive Symptoms in patients undergoing Intracranial tumOr resectioN (PASSION): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-08-29

主要终点为术后3天围术期抑郁症状应答率,次要终点包括缓解率、术后谵妄发生率、恢复质量及精神副作用等安全性指标。

要点

  • 氯胺酮组在剪开硬脑膜时静脉输注0.5 mg/kg氯胺酮40分钟。
  • 主要终点为术后3天围术期抑郁症状应答率。
  • 次要终点包括缓解率、术后谵妄、恢复质量及精神副作用。

核心结论

  • 该试验旨在确定氯胺酮能否改善幕上脑肿瘤切除术患者围术期抑郁症状,并考察其作为术中抗抑郁药的安全性。

研究设计与样本

  • 单中心、随机、安慰剂对照、双盲试验,按围术期抑郁症状严重程度(中度 vs 重度)分层随机。

关键数值与推荐

  • 氯胺酮组在剪开硬脑膜时静脉给予低剂量氯胺酮(0.5 mg/kg)输注40分钟。
  • 安慰剂组在相同时间点以相同输注速度给予相同体积的生理盐水。
  • 主要终点为术后3天围术期抑郁症状应答率。
  • 次要结局包括围术期抑郁症状缓解率、术后谵妄发生率、恢复质量及精神副作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Perioperative depressive symptoms (PDS) are common mental comorbidities that influence clinical outcomes and prognosis. However, there is no rapid-acting treatment to address these symptoms during a limited hospital stay. METHODS/DESIGN: This is a single-center, randomized, placebo-controlled, and double-blind trial. Randomization will be applied and stratified by the severity of PDS (moderate versus severe). Eighty patients who are scheduled for elective supratentorial brain tumor resection with PDS will be randomly allocated to the ketamine or placebo group with a ratio of 1 to 1. Patients in the ketamine group will be administered low-dose ketamine (0.5 mg/kg) intravenously for 40 min while the dural mater is being cut into, whereas patients in the placebo group will receive the same volume of normal saline at the same infusion rate at the same time points. The primary endpoint is the rate of PDS response at 3 days after surgery. Secondary outcomes include efficacy parameters such as the rate of PDS remission and safety outcomes such as the incidence of postoperative delirium, quality of recovery, and psychiatric side effects. DISCUSSION: This study aims to determine whether ketamine could improve the depressive symptoms of perioperative patients undergoing supratentorial brain tumor resection. It will also examine the safety of administering ketamine as an intraoperative anti-depressant. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03086148 . Registered on 22 March 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhou Y, Peng Y, Fang J, et al. Effect of low-dose ketamine on PerioperAtive depreSsive Symptoms in patients undergoing Intracranial tumOr resectioN (PASSION): study protocol for a randomized controlled trial. Trials. 2018. PMID: 30157913. doi:10.1186/s13063-018-2831-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。